Global Lice Treatment Market Segmentation, By Type (Pediculosis Capitis, Pediculosis Corporis, Pediculosis Pubis, and Others), Treatment (Ivermectin, Spinosad, Permethrin, Pyrethrin, and Other), Route of Administration (Oral, Topical, and Others), Dosage Form (Tablets, Shampoos, lotions, cream, and Others), End-Users (Hospitals, Specialty Clinics, Homecare, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others) – Industry Trends and Forecast to 2031
Lice Treatment Market Analysis
The lice treatment market is growing steadily, driven by the increasing prevalence of lice infestations, especially among school-going children. The market offers various solutions, including over-the-counter products such as shampoos, lotions, and prescription medications such as ivermectin and permethrin, addressing growing concerns about pesticide resistance in lice. Companies are focusing on developing chemical-free, natural alternatives, which are gaining popularity among health-conscious consumers. Recent developments include product launches from ParaPRO LLC and Arbor Pharmaceuticals, aimed at reducing re-infestation risks. With rising awareness campaigns and advancements in lice treatment formulations, the market is poised for significant growth, particularly in regions where lice infestations are prevalent, supporting the demand for new and effective solutions.
Lice Treatment Market Size
The global lice treatment market size was valued at USD 106.31 billion in 2023 and is projected to reach USD 177.94 billion by 2031, with a CAGR of 6.65% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Lice Treatment Market Trends
“Development of Pesticide-Free Treatments”
The lice treatment market is evolving as lice infestations remain a common issue, particularly among children. Innovations in this space include the development of pesticide-free treatments and solutions targeting pesticide-resistant lice strains. A key trend is the growing demand for natural, non-toxic lice treatments, as consumers become more aware of the potential side effects of chemical-based products. Companies are introducing advanced formulations, such as silicone-based treatments and enzyme-based products, which effectively combat lice without harmful chemicals. This shift towards safer, more effective treatments is driving market growth, particularly in regions with high lice infestation rates. Overall, the market is seeing a surge in product diversity and innovation, meeting consumer demands for more natural solutions.
Report Scope and Lice Treatment Market Segmentation
|
Attributes
|
Lice Treatment Key Market Insights
|
|
Segments Covered
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Key Market Players
|
F. Hoffmann-La Roche Ltd. (Switzerland), Viatris Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), AstraZeneca (U.K.), Johnson & Johnson Services, Inc. (U.S.), Bayer AG (Germany), Sun Pharmaceutical Industries Ltd. (India), Eli Lilly and Company (U.S.), Edenbridge Pharmaceuticals, LLC (U.S.), ParaPRO, LLC. (U.S.), Encube Ethicals Private Limited (India), GALDERMA (Switzerland), Alliance Pharma PLC (U.K.), Dr. Reddy's Laboratories Ltd. (India), Perrigo Company plc. (Ireland)
|
|
Market Opportunities
|
|
|
Value Added Data Infosets
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Lice Treatment Market Definition
Lice treatment refers to the medical or therapeutic approaches used to eliminate lice infestations, which are caused by parasitic insects that typically infest the hair and scalp of humans. Common types of lice include head lice (Pediculus humanus capitis), body lice (Pediculus humanus corporis), and pubic lice (Pthirus pubis). Treatments may involve the use of over-the-counter or prescription insecticidal shampoos, lotions, and sprays that contain active ingredients such as permethrin, pyrethrin, or malathion.
Lice Treatment Market Dynamics
Drivers
- Increasing Incidence of Lice Infestations
The increasing prevalence of head lice infestations, especially among school-aged children, is a significant driver of the lice treatment market. Schools and daycare centers serve as common breeding grounds for these pests, leading to frequent outbreaks that can quickly spread among students. As awareness of lice infestations grows, parents and caregivers become more proactive in seeking effective treatment solutions. The visibility of outbreaks often prompts schools to implement policies for lice checks and treatment guidelines, further heightening awareness among families. Consequently, this increased concern translates into a surge in the demand for lice treatment products. Such dynamics create a robust market for effective and safe solutions, reinforcing the importance of addressing head lice infestations in educational settings.
- Rising Demand for Over-the-Counter Products
The availability of effective over-the-counter (OTC) lice treatment solutions plays a crucial role in driving the lice treatment market. Consumers appreciate the convenience of having readily accessible options for managing lice infestations, as these treatments can often be purchased without a prescription. This ease of access allows individuals and families to respond quickly to outbreaks, providing immediate relief from the discomfort and social stigma associated with lice. Furthermore, the variety of OTC products, which include shampoos, lotions, and sprays, caters to diverse preferences and needs, further enhancing consumer appeal. As awareness of lice infestations grows, so does the inclination to seek out these convenient treatments, resulting in increased sales and a thriving market for lice treatment solutions.
Opportunities
- Innovative Product Development
The lice treatment market is poised for growth through significant investments in research and development aimed at creating more effective and safer products. Companies have the opportunity to innovate by developing natural or organic formulations that cater to the increasing demand among health-conscious consumers seeking safer alternatives. These formulations can differentiate products in a competitive market, addressing consumer concerns about chemical exposure, especially for children. In addition, advancements in delivery systems, such as lice treatment shampoo or sprays that incorporate essential oils known for their insecticidal properties, can enhance efficacy and consumer appeal. By focusing on these innovations, companies can capture a larger market share and foster brand loyalty among consumers who prioritize health and safety in their purchasing decisions.
- Digital Marketing and E-commerce
The surge in online shopping has created a valuable opportunity for lice treatment brands to expand their reach and connect with a wider audience. With consumers increasingly turning to digital platforms for their purchasing needs, companies can leverage enhanced digital marketing strategies to improve brand visibility and drive sales. This trend has been particularly pronounced since the COVID-19 pandemic, as more individuals seek home care solutions, including effective lice treatments, that can be conveniently purchased from the comfort of their homes. By optimizing their online presence through social media, search engine marketing, and targeted advertising campaigns, lice treatment brands can effectively engage with consumers, address their concerns, and promote their products. Capitalizing on this shift toward e-commerce enhances sales potential and fosters a loyal customer base in an evolving retail landscape.
Restraints/Challenges
- Competition from Alternatives Treatments
The increasing popularity of alternative treatments and home remedies for lice infestations presents a significant challenge in the lice treatment market. Many consumers are turning to these options, often perceived as more natural or safer, despite a lack of scientific validation regarding their effectiveness. This trend can undermine confidence in traditional over-the-counter and prescription treatments, potentially leading to decreased sales for established brands. The rise of social media and online platforms further amplifies the visibility of these alternatives, making it easier for individuals to find and share anecdotal success stories. As a result, manufacturers of clinically tested lice treatments must work harder to educate consumers about the proven efficacy of their products while addressing the growing preference for non-traditional solutions.
- Side Effects and Allergic Reactions
Some consumers may encounter side effects or allergic reactions when using chemical lice treatments, leading to reluctance in using these products. Common side effects can include scalp irritation, redness, itching, and, in more severe cases, systemic reactions. This discomfort can deter individuals from opting for chemical solutions, prompting them to seek alternative treatments, such as natural or herbal remedies. As awareness of these potential adverse effects grows, consumers are increasingly inclined to choose safer options, impacting the sales of traditional lice treatments. Consequently, the preference for alternative remedies poses a significant restraint on the lice treatment market, challenging manufacturers to innovate and improve the safety profile of their products to retain consumer trust and market share.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Lice Treatment Market Scope
The market is segmented on the basis of type, treatment, route of administration, dosage form, end-users, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Pediculosis Capitis
- Pediculosis Corporis
- Pediculosis Pubis
- Others
Treatment
- Ivermectin
- Spinosad
- Permethrin
- Pyrethrin
- Others
Route of Administration
- Oral
- Topical
- Others
Dosage Form
- Tablets
- Shampoos
- Lotions
- Cream
- Others
End-Users
- Hospitals
- Specialty Clinics
- Homecare
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Lice Treatment Market Regional Analysis
The market is analysed and market size insights and trends are provided by country, type, treatment, route of administration, dosage form, end-users, and distribution channel as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America leads the lice treatment market, driven by a growing population of children and the presence of prominent industry players. Furthermore, increasing healthcare spending in the region is expected to enhance market growth. This combination of factors positions North America as a key player in the lice treatment industry.
Asia-Pacific region is anticipated to experience significant growth from 2024 to 2031, primarily due to the presence of numerous generic manufacturers. In addition, improvements in healthcare infrastructure, coupled with rising incidences of lice infestations, are expected to drive market expansion. These factors collectively position the Asia-Pacific market for robust growth in the lice treatment sector.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Lice Treatment Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Lice Treatment Market Leaders Operating in the Market Are:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Viatris Inc. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Sanofi (France)
- Pfizer Inc. (U.S.)
- GSK plc (U.K.)
- Novartis AG (Switzerland)
- AstraZeneca (U.K.)
- Johnson & Johnson Services, Inc. (U.S.)
- Bayer AG (Germany)
- Sun Pharmaceutical Industries Ltd. (India)
- Eli Lilly and Company (U.S.)
- Edenbridge Pharmaceuticals, LLC (U.S.)
- ParaPRO, LLC. (U.S.)
- Encube Ethicals Private Limited (India)
- GALDERMA (Switzerland)
- Alliance Pharma PLC (U.K.)
- Dr. Reddy's Laboratories Ltd. (India)
- Perrigo Company plc. (Ireland)
Latest Developments in Lice Treatment Market
- In October 2022, Alliance Pharmaceuticals launched a clinical trial in collaboration with South Florida Family Health and Research Centers to evaluate the safety and efficacy of Vamousse Spray 'n' Go. This trial compares the spray to a 1% Permethrin control shampoo for treating head lice infestations. The study aims to deliver crucial insights into the effectiveness of Vamousse Spray 'n' Go, potentially positioning it as a valuable alternative or enhancement to current lice treatment options
- In September 2022, the American Academy of Pediatrics updated its guidelines for the identification and treatment of head lice. The revisions included the introduction of new medications for effective treatment and presented a clear algorithm for managing affected patients. These updates aim to enhance clarity on diagnosis and treatment options for head lice infestations
- In August 2021, ParaPRO, a specialty pharmaceutical company, announced the launch of Natroba (spinosad) Topical Suspension, 0.9%, marking the first FDA-approved treatment for scabies. This approval signifies a significant advancement in scabies therapy by offering a targeted topical option. The introduction of Natroba enhances the company’s product portfolio and strengthens its position in the market
- In October 2021, Lice Clinics of America announced the successful completion of 750,000 head lice treatments using heated air technology, achieving a remarkable 95% success rate. This innovative approach has positioned the clinics as a leading option for effective lice removal. The high success rate highlights the effectiveness of their treatment method in combating head lice infestations
SKU-